Journal List > Tuberc Respir Dis > v.66(1) > 1001391

Park, Lee, Lim, Lee, Hwangbo, and Lee: Gastric Metastasis of Primary Lung Adenocarcinoma Mistaken for Primary Gastric Cancer

Abstract

The stomach is a rare site for metastasis, with autopsy incidence rates of 0.2% to 1.7%. This low rate makes diagnosis of metastatic gastric cancer challenging for clinicians. The authors report a case of a 64-year-old man diagnosed with gastric metastasis of primary lung adenocarcinoma that was initially mistaken for primary gastric cancer, as well as a review of the medical literature.

Figures and Tables

Figure 1
Initial gastrofiberscopy showed 3.2 cm sized polypoid mass with ulceration in the body of stomach.
trd-66-52-g001
Figure 2
(A) Chest X-ray taken during the admission for gastrectomy showed a ground-glass opacity (GGO) lesion in the right upper lobe. (B) CT scan taken 2 months after subtotal gastrectomy showed a GGO lesion with solid portion in the right upper lobe. (C, D) Chest X-ray and CT scan taken 11 months after right upper lobectomy showed a mass with surrounding ground-glass opacity in the left lower lobe.
trd-66-52-g002
Figure 3
(A) Hematoxylin and eosin (H&E) stain in the lung tissue obtained by percutaneous needle biopsy (×100). A papillary pattern and undifferentiated diffuse proliferation, suggesting poorly differentiated adenocarcinoma are observed. (B) Immunohistochemical stain for thyroid transcription factor-1 (TTF-1) in the lung tissue obtained by percutaneous needle biopsy (×100). The strong positive staining with TTF-1 is observed. (C) H&E stain in the gastrectomy specimen (×100). The tumor cells of stomach are similar to the adenocarcinoma observed in the lung tissue. (D) Immunohistochemical stain for TTF-1 in the gastrectomy specimen (×100). The strong positive staining with TTF-1 is observed.
trd-66-52-g003
Table 1
Gastric metastases listed by their primary sites
trd-66-52-i001

*One case of duodenal metastasis from osteogenic sarcoma was excluded in the table, Three cases of duodenal metastasis from renal transitional cell carcinoma (2 cases) and colon cancer (1 case) were excluded in the table.

References

1. Kadakia SC, Parker A, Canales L. Metastatic tumors to the upper gastrointestinal tract: endoscopic experience. Am J Gastroenterol. 1992. 87:1418–1423.
2. Menuck LS, Amberg JR. Metastatic disease involving the stomach. Am J Dig Dis. 1975. 20:903–913.
3. Wu MH, Lin MT, Lee PH. Clinicopathological study of gastric metastases. World J Surg. 2007. 31:132–136.
4. Green LK. Hematogenous metastases to the stomach: a review of 67 cases. Cancer. 1990. 65:1596–1600.
5. Oda , Kondo H, Yamao T, Saito D, Ono H, Gotoda T, et al. Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy. 2001. 33:507–510.
6. Hsu CC, Chen JJ, Changchien CS. Endoscopic features of metastatic tumors in the upper gastrointestinal tract. Endoscopy. 1996. 28:249–253.
7. Campoli PM, Ejima FH, Cardoso DM, Silva OQ, Santana Filho JB, Queiroz Barreto PA, et al. Metastatic cancer to the stomach. Gastric Cancer. 2006. 9:19–25.
8. Kim HS, Jang WI, Hong HS, Lee CI, Lee DK, Yong SJ, et al. Metastatic involvement of the stomach secondary to lung carcinoma. J Korean Med Sci. 1993. 8:24–29.
9. Kim HG, Kim YS, Choi SD, Won YJ, Jung JH, Sue YB, et al. A case of squamous cell lung cancer with metastasis of the stomach. Korean J Gastrointest Endosc. 1998. 18:900–907.
10. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R. A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J. 1989. 8:2537–2542.
11. Moldvay J, Jackel M, Bogos K, Soltész I, Agócs L, Kovács G, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004. 10:85–88.
12. Roh MS, Hong SH. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. J Korean Med Sci. 2002. 17:512–517.
13. Su YC, Hsu YC, Chai CY. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Kaohsiung J Med Sci. 2006. 22:14–19.
14. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003. 27:303–310.
15. Park SY, Kim BH, Kim JH, Lee S, Kang GH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med. 2007. 131:1561–1567.
TOOLS
Similar articles